Form 8-K - Current report:
SEC Accession No. 0001001233-25-000006
Filing Date
2025-09-04
Accepted
2025-09-04 08:06:44
Documents
24
Period of Report
2025-09-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20250904.htm   iXBRL 8-K 64376
5 GRAPHIC sgmo-20250904_g1.jpg GRAPHIC 200837
6 GRAPHIC sgmo-20250904_g10.jpg GRAPHIC 338725
7 GRAPHIC sgmo-20250904_g11.jpg GRAPHIC 213940
8 GRAPHIC sgmo-20250904_g12.jpg GRAPHIC 221560
9 GRAPHIC sgmo-20250904_g2.jpg GRAPHIC 267287
10 GRAPHIC sgmo-20250904_g3.jpg GRAPHIC 293450
11 GRAPHIC sgmo-20250904_g4.jpg GRAPHIC 183092
12 GRAPHIC sgmo-20250904_g5.jpg GRAPHIC 144412
13 GRAPHIC sgmo-20250904_g6.jpg GRAPHIC 234882
14 GRAPHIC sgmo-20250904_g7.jpg GRAPHIC 253324
15 GRAPHIC sgmo-20250904_g8.jpg GRAPHIC 151635
16 GRAPHIC sgmo-20250904_g9.jpg GRAPHIC 238335
  Complete submission text file 0001001233-25-000006.txt   6855599

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20250904.xsd EX-101.SCH 1795
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20250904_lab.xml EX-101.LAB 21880
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20250904_pre.xml EX-101.PRE 12520
26 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20250904_htm.xml XML 2714
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 251291927
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)